NVS logo

Novartis AG (NVS) CAPEX

Annual CAPEX

$3.81 B
+$1.06 B+38.54%

December 31, 2024


Summary


Performance

NVS CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVScash flowmetrics:

Quarterly CAPEX

$1.13 B
+$332.00 M+41.55%

December 31, 2024


Summary


Performance

NVS Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVScash flowmetrics:

TTM CAPEX

$3.81 B
+$348.00 M+10.04%

December 31, 2024


Summary


Performance

NVS TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVScash flowmetrics:

NVS CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+38.5%+44.4%+38.5%
3 y3 years+49.2%+65.6%+54.5%
5 y5 years+69.0%+65.6%+54.5%

NVS CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+70.3%-2.2%+278.3%at high+115.6%
5 y5-yearat high+70.3%-2.2%+278.3%at high+115.6%
alltimeall timeat high+355.1%-15.5%+416.4%at high+1641.5%

Novartis AG CAPEX History

DateAnnualQuarterlyTTM
Dec 2024
$3.81 B(+38.5%)
$1.13 B(+41.6%)
$3.81 B(+10.0%)
Sep 2024
-
$799.00 M(+9.8%)
$3.47 B(+3.5%)
Jun 2024
-
$728.00 M(-37.0%)
$3.35 B(-4.8%)
Mar 2024
-
$1.16 B(+47.6%)
$3.52 B(+27.9%)
Dec 2023
$2.75 B(+23.0%)
$783.00 M(+14.6%)
$2.75 B(+11.5%)
Sep 2023
-
$683.00 M(-23.9%)
$2.47 B(+18.4%)
Jun 2023
-
$898.00 M(+130.8%)
$2.08 B(+17.8%)
Mar 2023
-
$389.00 M(-21.9%)
$1.77 B(-21.0%)
Dec 2022
$2.24 B(-12.4%)
$498.00 M(+66.6%)
$2.24 B(-2.8%)
Sep 2022
-
$299.00 M(-48.7%)
$2.30 B(-9.4%)
Jun 2022
-
$583.00 M(-32.1%)
$2.54 B(-0.5%)
Mar 2022
-
$859.00 M(+52.8%)
$2.56 B(+0.0%)
Dec 2021
$2.56 B(-1.1%)
$562.00 M(+4.3%)
$2.56 B(-15.3%)
Sep 2021
-
$539.00 M(-9.7%)
$3.02 B(-2.8%)
Jun 2021
-
$597.00 M(-30.4%)
$3.10 B(+4.9%)
Mar 2021
-
$858.00 M(-16.1%)
$2.96 B(+14.5%)
Dec 2020
$2.58 B(+14.5%)
$1.02 B(+63.2%)
$2.58 B(+17.6%)
Sep 2020
-
$627.00 M(+38.7%)
$2.20 B(+3.0%)
Jun 2020
-
$452.00 M(-6.4%)
$2.13 B(+0.6%)
Mar 2020
-
$483.00 M(-24.1%)
$2.12 B(-6.0%)
Dec 2019
$2.26 B(-14.8%)
$636.00 M(+13.2%)
$2.26 B(-0.6%)
Sep 2019
-
$562.00 M(+27.7%)
$2.27 B(-10.9%)
Jun 2019
-
$440.00 M(-28.9%)
$2.55 B(-1.7%)
Mar 2019
-
$619.00 M(-4.8%)
$2.59 B(-2.1%)
Dec 2018
$2.65 B(+15.4%)
$650.00 M(-22.7%)
$2.65 B(+5.2%)
Sep 2018
-
$841.00 M(+74.1%)
$2.52 B(+7.3%)
Jun 2018
-
$483.00 M(-28.3%)
$2.34 B(-2.9%)
Mar 2018
-
$674.00 M(+30.1%)
$2.41 B(+5.2%)
Dec 2017
$2.29 B(-20.3%)
$518.00 M(-22.6%)
$2.29 B(-10.3%)
Sep 2017
-
$669.00 M(+21.0%)
$2.56 B(-1.7%)
Jun 2017
-
$553.00 M(-0.2%)
$2.60 B(-4.5%)
Mar 2017
-
$554.00 M(-29.1%)
$2.72 B(-5.4%)
Dec 2016
$2.88 B(-17.9%)
$781.00 M(+9.4%)
$2.88 B(-6.1%)
Sep 2016
-
$714.00 M(+5.8%)
$3.07 B(-2.1%)
Jun 2016
-
$675.00 M(-4.8%)
$3.13 B(-10.5%)
Mar 2016
-
$709.00 M(-26.8%)
$3.50 B(-0.2%)
Dec 2015
$3.50 B(+3.0%)
$968.00 M(+24.1%)
$3.50 B(+3.9%)
Sep 2015
-
$780.00 M(-25.1%)
$3.37 B(-6.1%)
Jun 2015
-
$1.04 B(+45.7%)
$3.59 B(+2.3%)
Mar 2015
-
$715.00 M(-14.4%)
$3.51 B(+3.1%)
Dec 2014
$3.40 B(+0.8%)
$835.00 M(-16.4%)
$3.40 B(-6.6%)
Sep 2014
-
$999.00 M(+3.8%)
$3.65 B(+3.4%)
Jun 2014
-
$962.00 M(+58.2%)
$3.52 B(+5.7%)
Mar 2014
-
$608.00 M(-43.5%)
$3.34 B(-1.2%)
Dec 2013
$3.38 B
$1.08 B(+22.4%)
$3.38 B(+13.3%)
Sep 2013
-
$879.00 M(+13.7%)
$2.98 B(+4.3%)
DateAnnualQuarterlyTTM
Jun 2013
-
$773.00 M(+18.9%)
$2.86 B(+2.1%)
Mar 2013
-
$650.00 M(-4.3%)
$2.80 B(+0.9%)
Dec 2012
$2.77 B(+16.1%)
$679.00 M(-10.1%)
$2.77 B(+0.2%)
Sep 2012
-
$755.00 M(+5.7%)
$2.77 B(+6.6%)
Jun 2012
-
$714.00 M(+14.4%)
$2.60 B(+3.6%)
Mar 2012
-
$624.00 M(-7.3%)
$2.50 B(+4.9%)
Dec 2011
$2.39 B(+6.9%)
$673.00 M(+15.2%)
$2.39 B(-2.9%)
Sep 2011
-
$584.00 M(-6.4%)
$2.46 B(+8.5%)
Jun 2011
-
$624.00 M(+23.3%)
$2.27 B(-1.0%)
Mar 2011
-
$506.00 M(-32.0%)
$2.29 B(+2.6%)
Dec 2010
$2.23 B(-18.3%)
$744.00 M(+89.8%)
$2.23 B(-10.1%)
Sep 2010
-
$392.00 M(-39.5%)
$2.48 B(-4.8%)
Jun 2010
-
$648.00 M(+44.6%)
$2.61 B(-2.7%)
Mar 2010
-
$448.00 M(-54.9%)
$2.68 B(-2.0%)
Dec 2009
$2.73 B(+18.0%)
$994.00 M(+92.6%)
$2.73 B(+17.1%)
Sep 2009
-
$516.00 M(-28.2%)
$2.33 B(-3.0%)
Jun 2009
-
$719.00 M(+42.7%)
$2.41 B(-0.5%)
Mar 2009
-
$504.00 M(-15.3%)
$2.42 B(+4.4%)
Dec 2008
$2.32 B(-26.1%)
$595.00 M(+1.2%)
$2.32 B(-24.3%)
Sep 2008
-
$588.00 M(-19.5%)
$3.06 B(-2.0%)
Jun 2008
-
$730.00 M(+81.1%)
$3.12 B(+3.6%)
Mar 2008
-
$403.00 M(-69.9%)
$3.01 B(-3.8%)
Dec 2007
$3.13 B(+40.5%)
$1.34 B(+105.8%)
$3.13 B(+7.7%)
Sep 2007
-
$650.00 M(+4.3%)
$2.91 B(+6.4%)
Jun 2007
-
$623.00 M(+19.3%)
$2.73 B(+11.6%)
Mar 2007
-
$522.00 M(-53.1%)
$2.45 B(+9.9%)
Dec 2006
$2.23 B(+61.6%)
$1.11 B(+133.8%)
$2.23 B(+29.1%)
Sep 2006
-
$476.00 M(+40.4%)
$1.73 B(+12.4%)
Jun 2006
-
$339.00 M(+12.3%)
$1.54 B(+5.2%)
Mar 2006
-
$302.00 M(-50.5%)
$1.46 B(+5.8%)
Dec 2005
$1.38 B(-4.1%)
$610.00 M(+114.0%)
$1.38 B(+4.0%)
Sep 2005
-
$285.00 M(+8.4%)
$1.33 B(-0.9%)
Jun 2005
-
$263.00 M(+18.5%)
$1.34 B(-4.5%)
Mar 2005
-
$222.00 M(-60.1%)
$1.40 B(-2.6%)
Dec 2004
$1.44 B(-6.7%)
$557.00 M(+87.5%)
$1.44 B(-10.0%)
Sep 2004
-
$297.00 M(-8.9%)
$1.60 B(-0.9%)
Jun 2004
-
$326.00 M(+25.9%)
$1.61 B(+1.9%)
Mar 2004
-
$259.00 M(-63.9%)
$1.58 B(+2.6%)
Dec 2003
$1.54 B(+33.2%)
$717.00 M(+130.5%)
$1.54 B(+86.8%)
Sep 2003
-
$311.00 M(+5.1%)
$826.00 M(+60.4%)
Jun 2003
-
$296.00 M(+35.2%)
$515.00 M(+135.2%)
Mar 2003
-
$219.00 M
$219.00 M
Dec 2002
$1.16 B(-16.1%)
-
-
Dec 2001
$1.38 B(+64.8%)
-
-
Dec 2000
$838.00 M(-2.7%)
-
-
Dec 1999
$861.00 M(-24.9%)
-
-
Dec 1998
$1.15 B
-
-

FAQ

  • What is Novartis AG annual capital expenditures?
  • What is the all time high annual CAPEX for Novartis AG?
  • What is Novartis AG annual CAPEX year-on-year change?
  • What is Novartis AG quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Novartis AG?
  • What is Novartis AG quarterly CAPEX year-on-year change?
  • What is Novartis AG TTM capital expenditures?
  • What is the all time high TTM CAPEX for Novartis AG?
  • What is Novartis AG TTM CAPEX year-on-year change?

What is Novartis AG annual capital expenditures?

The current annual CAPEX of NVS is $3.81 B

What is the all time high annual CAPEX for Novartis AG?

Novartis AG all-time high annual capital expenditures is $3.81 B

What is Novartis AG annual CAPEX year-on-year change?

Over the past year, NVS annual capital expenditures has changed by +$1.06 B (+38.54%)

What is Novartis AG quarterly capital expenditures?

The current quarterly CAPEX of NVS is $1.13 B

What is the all time high quarterly CAPEX for Novartis AG?

Novartis AG all-time high quarterly capital expenditures is $1.34 B

What is Novartis AG quarterly CAPEX year-on-year change?

Over the past year, NVS quarterly capital expenditures has changed by +$348.00 M (+44.44%)

What is Novartis AG TTM capital expenditures?

The current TTM CAPEX of NVS is $3.81 B

What is the all time high TTM CAPEX for Novartis AG?

Novartis AG all-time high TTM capital expenditures is $3.81 B

What is Novartis AG TTM CAPEX year-on-year change?

Over the past year, NVS TTM capital expenditures has changed by +$1.06 B (+38.54%)